A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia

Anamorelin (ANA) is approved for treating cancer cachexia (CCX) in Japan. We report the case of a 69-year-old man with stage IVB squamous cell lung cancer complicated by CCX, having a 13.6% weight loss in 6 months. After chemotherapy was initiated, his weight was further reduced. Therefore, we start...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshima, Yuri, Matsuura, Hiroyuki, Sakurai, Yusuke, Hirai, Kaho, Tani, Eriko, Yoshimoto, Naoki, Minami, Kenichi, Yamasaki, Fumio, Nishime, Mayu, Hirashima, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866093/
https://www.ncbi.nlm.nih.gov/pubmed/35242522
http://dx.doi.org/10.1016/j.rmcr.2022.101609
_version_ 1784655761435000832
author Oshima, Yuri
Matsuura, Hiroyuki
Sakurai, Yusuke
Hirai, Kaho
Tani, Eriko
Yoshimoto, Naoki
Minami, Kenichi
Yamasaki, Fumio
Nishime, Mayu
Hirashima, Tomonori
author_facet Oshima, Yuri
Matsuura, Hiroyuki
Sakurai, Yusuke
Hirai, Kaho
Tani, Eriko
Yoshimoto, Naoki
Minami, Kenichi
Yamasaki, Fumio
Nishime, Mayu
Hirashima, Tomonori
author_sort Oshima, Yuri
collection PubMed
description Anamorelin (ANA) is approved for treating cancer cachexia (CCX) in Japan. We report the case of a 69-year-old man with stage IVB squamous cell lung cancer complicated by CCX, having a 13.6% weight loss in 6 months. After chemotherapy was initiated, his weight was further reduced. Therefore, we started ANA combined with a treatment approach by a multidisciplinary collaboration, including nutritionists and physical therapists. After initiation of ANA, the body weight, appetite, psoas muscle index, and physical functions rapidly improved during chemotherapy. ANA administration combined with a multidisciplinary collaboration approach can be an effective supportive therapy against CCX during chemotherapy.
format Online
Article
Text
id pubmed-8866093
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88660932022-03-02 A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia Oshima, Yuri Matsuura, Hiroyuki Sakurai, Yusuke Hirai, Kaho Tani, Eriko Yoshimoto, Naoki Minami, Kenichi Yamasaki, Fumio Nishime, Mayu Hirashima, Tomonori Respir Med Case Rep Case Report Anamorelin (ANA) is approved for treating cancer cachexia (CCX) in Japan. We report the case of a 69-year-old man with stage IVB squamous cell lung cancer complicated by CCX, having a 13.6% weight loss in 6 months. After chemotherapy was initiated, his weight was further reduced. Therefore, we started ANA combined with a treatment approach by a multidisciplinary collaboration, including nutritionists and physical therapists. After initiation of ANA, the body weight, appetite, psoas muscle index, and physical functions rapidly improved during chemotherapy. ANA administration combined with a multidisciplinary collaboration approach can be an effective supportive therapy against CCX during chemotherapy. Elsevier 2022-02-17 /pmc/articles/PMC8866093/ /pubmed/35242522 http://dx.doi.org/10.1016/j.rmcr.2022.101609 Text en © 2022 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Oshima, Yuri
Matsuura, Hiroyuki
Sakurai, Yusuke
Hirai, Kaho
Tani, Eriko
Yoshimoto, Naoki
Minami, Kenichi
Yamasaki, Fumio
Nishime, Mayu
Hirashima, Tomonori
A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia
title A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia
title_full A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia
title_fullStr A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia
title_full_unstemmed A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia
title_short A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia
title_sort case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866093/
https://www.ncbi.nlm.nih.gov/pubmed/35242522
http://dx.doi.org/10.1016/j.rmcr.2022.101609
work_keys_str_mv AT oshimayuri acaseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT matsuurahiroyuki acaseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT sakuraiyusuke acaseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT hiraikaho acaseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT tanieriko acaseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT yoshimotonaoki acaseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT minamikenichi acaseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT yamasakifumio acaseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT nishimemayu acaseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT hirashimatomonori acaseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT oshimayuri caseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT matsuurahiroyuki caseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT sakuraiyusuke caseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT hiraikaho caseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT tanieriko caseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT yoshimotonaoki caseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT minamikenichi caseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT yamasakifumio caseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT nishimemayu caseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia
AT hirashimatomonori caseofsquamouscelllungcancertreatedwithanamorelinincombinationwithamultidisciplinarycollaborativeapproachfortreatingcancercachexia

Ejemplares similares